U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07240311) titled 'Evaluation of AmblyoFix for the Treatment of Unilateral Amblyopia' on Sept. 30.
Brief Summary: This is a prospective, randomized, parallel-group, assessor-masked, non-inferiority clinical trial designed to compare the efficacy, safety, and adherence of AmblyoFix binocular digital therapy with standard occlusion (patching) for the treatment of unilateral amblyopia in children and young adults aged 8 to 35 years. In the event that adequate recruitment within this age range is not feasible, the age range may be modified, subject to appropriate ethical approval and protocol amendment procedures.
A total of 86 participants will be enrol...